Download PDF
Semin Reprod Med 2024; 42(03): 209-227
DOI: 10.1055/s-0044-1793827
Review Article

Impact of Systemic Lupus Erythematosus on Conception: Insights into Infertility, Fertility Preservation, Assisted Reproductive Technology, and Pregnancy Outcomes

Amanda Moyer 
2   Department of Medicine, Division of Immunology and Rheumatology and Department of Pediatrics, Division of Allergy, Immunology, and Rheumatology, Stanford Medicine, Stanford, California
,
Cuoghi Edens 
1   Sections of Rheumatology and Pediatric Rheumatology, University of Chicago Medicine, Chicago, Illinois
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Many individuals with systemic lupus erythematosus (SLE) face significant challenges manifesting their family planning goals due to numerous factors, including disease-related complications, treatment-induced effects, immunological factors, self-imposed limitations, and the socioeconomic impacts of having a chronic disease. Instances of unexplained infertility are also prevalent. Encouragingly, advancements in treatment modalities, risk factor management, specialized training within the medical community, and enhanced patient/provider education have contributed to an increase in successful pregnancies among SLE patients, fostering a safer, more promising reproductive landscape. However, despite advances, individuals with SLE continue to struggle with the complexities of family building. This review explores infertility and pregnancy outcomes in SLE, fertility preservation, the role of assisted reproductive technology, and considerations for tailoring these approaches to SLE patients.

Keywords

infertility - systemic lupus erythematosus - pregnancy - assisted reproductive technology - surrogacy


Publication History

Article published online:
12 December 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Lu W, Tian F, Ma J, Zhong Y, Liu Z, Xue L. Diagnostic accuracy of the European League against rheumatism/American College of Rheumatology-2019 versus the Systemic Lupus International Collaborating Clinics-2012 versus the ACR-1997 classification criteria in adult systemic lupus erythematosus: a systematic review and meta-analysis. Front Immunol 2022; 13: 1023451
    CrossrefPubMedSearch in Google Scholar
  • 2 Aringer M, Costenbader K, Daikh D. et al. European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol 2019; 71 (09) 1400-1412
    CrossrefPubMedSearch in Google Scholar
  • 3 Petri M, Orbai AM, Alarcón GS. et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012; 64 (08) 2677-2686
    CrossrefPubMedSearch in Google Scholar
  • 4 Izmirly PM, Parton H, Wang L. et al. Prevalence of systemic lupus erythematosus in the United States: estimates from a meta-analysis of the Centers for Disease Control and Prevention National Lupus Registries. Arthritis Rheumatol 2021; 73 (06) 991-996
    CrossrefPubMedSearch in Google Scholar
  • 5 He WR, Wei H. Maternal and fetal complications associated with systemic lupus erythematosus: an updated meta-analysis of the most recent studies (2017-2019). Medicine (Baltimore) 2020; 99 (16) e19797
    CrossrefPubMedSearch in Google Scholar
  • 6 Mehta B, Luo Y, Xu J. et al. Trends in maternal and fetal outcomes among pregnant women with systemic lupus erythematosus in the United States. Ann Intern Med 2019; 171 (03) 164-171
    CrossrefPubMedSearch in Google Scholar
  • 7 Bundhun PK, Soogund MZS, Huang F. Impact of systemic lupus erythematosus on maternal and fetal outcomes following pregnancy: a meta-analysis of studies published between years 2001-2016. J Autoimmun 2017; 79: 17-27
    CrossrefPubMedSearch in Google Scholar
  • 8 Clowse MEB, Jamison M, Myers E, James AH. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol 2008; 199 (02) 127.e1-127.e6
    CrossrefPubMedSearch in Google Scholar
  • 9 Vinet E, Labrecque J, Pineau CA. et al. A population-based assessment of live births in women with systemic lupus erythematosus. Ann Rheum Dis 2012; 71 (04) 557-559
    CrossrefPubMedSearch in Google Scholar
  • 10 Vinet E, Clarke AE, Gordon C. et al. Decreased live births in women with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2011; 63 (07) 1068-1072
    CrossrefPubMedSearch in Google Scholar
  • 11 Clowse MEB, Chakravarty E, Costenbader KH, Chambers C, Michaud K. Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2012; 64 (05) 668-674
    CrossrefPubMedSearch in Google Scholar
  • 12 Wang X, Li J, Liang Q. et al. Reproductive concerns and contributing factors in women of childbearing age with systemic lupus erythematosus. Clin Rheumatol 2022; 41 (08) 2383-2391
    CrossrefPubMedSearch in Google Scholar
  • 13 Vinet E, Pineau C, Gordon C, Clarke AE, Bernatsky S. Systemic lupus erythematosus in women: impact on family size. Arthritis Rheum 2008; 59 (11) 1656-1660
    CrossrefPubMedSearch in Google Scholar
  • 14 Hickman RA, Gordon C. Causes and management of infertility in systemic lupus erythematosus. Rheumatology (Oxford) 2011; 50 (09) 1551-1558
    CrossrefPubMedSearch in Google Scholar
  • 15 Trentin F, Signorini V, Manca ML. et al. Gender differences in SLE: report from a cohort of 417 Caucasian patients. Lupus Sci Med 2023; 10 (01) e000880
    CrossrefPubMedSearch in Google Scholar
  • 16 Krasselt M, Baerwald C. Sex, symptom severity, and quality of life in rheumatology. Clin Rev Allergy Immunol 2019; 56 (03) 346-361
    CrossrefPubMedSearch in Google Scholar
  • 17 Carson SA, Kallen AN. Diagnosis and management of infertility: a review. JAMA 2021; 326 (01) 65-76
    CrossrefPubMedSearch in Google Scholar
  • 18 Definition of infertility: a committee opinion (2023) | American Society for Reproductive Medicine | ASRM. Accessed April 16, 2024 at: https://www.asrm.org/practice-guidance/practice-committee-documents/denitions-of-infertility/
    PubMed
  • 19 Stamm B, Barbhaiya M, Siegel C, Lieber S, Lockshin M, Sammaritano L. Infertility in systemic lupus erythematosus: what rheumatologists need to know in a new age of assisted reproductive technology. Lupus Sci Med 2022; 9 (01) e000840
    CrossrefPubMedSearch in Google Scholar
  • 20 Breitkopf DM, Hill M. Infertility workup for the women's health specialist: ACOG Committee Opinion Summary, Number 781. Obstet Gynecol 2019; 133 (06) 1294-1295
    CrossrefPubMedSearch in Google Scholar
  • 21 Sammaritano LR, Bermas BL, Chakravarty EE. et al. 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis Care Res (Hoboken) 2020; 72 (04) 461-488
    CrossrefPubMedSearch in Google Scholar
  • 22 Schlegel PN, Sigman M, Collura B. et al. Diagnosis and treatment of infertility in men: AUA/ASRM guideline part I. Fertil Steril 2021; 115 (01) 54-61
    CrossrefPubMedSearch in Google Scholar
  • 23 Schlegel PN, Sigman M, Collura B. et al. Diagnosis and treatment of infertility in men: AUA/ASRM guideline part II. Fertil Steril 2021; 115 (01) 62-69
    CrossrefPubMedSearch in Google Scholar
  • 24 NamGoung SJ, Chang Y, Kim Y. et al. Low anti-Müllerian hormone levels are associated with an increased risk of incident early-onset vasomotor symptoms among premenopausal women. Sci Rep 2022; 12 (01) 1-7
    CrossrefPubMedSearch in Google Scholar
  • 25 Zheng H, Chen S, Du H. et al. Ovarian response prediction in controlled ovarian stimulation for IVF using anti-Müllerian hormone in Chinese women: a retrospective cohort study. Medicine (Baltimore) 2017; 96 (13) e6495
    CrossrefPubMedSearch in Google Scholar
  • 26 Pastore LM, Christianson MS, Stelling J, Kearns WG, Segars JH. Reproductive ovarian testing and the alphabet soup of diagnoses: DOR, POI, POF, POR, and FOR. J Assist Reprod Genet 2018; 35 (01) 17-23
    CrossrefPubMedSearch in Google Scholar
  • 27 Angley M, Spencer JB, Lim SS, Howards PP. Anti-Müllerian hormone in African-American women with systemic lupus erythematosus. Lupus Sci Med 2020; 7 (01) e000439
    CrossrefPubMedSearch in Google Scholar
  • 28 Gao H, Ma J, Wang X. et al. Preliminary study on the changes of ovarian reserve, menstruation, and lymphocyte subpopulation in systemic lupus erythematosus (SLE) patients of childbearing age. Lupus 2018; 27 (03) 445-453
    CrossrefPubMedSearch in Google Scholar
  • 29 Lawrenz B, Henes J, Henes M. et al. Impact of systemic lupus erythematosus on ovarian reserve in premenopausal women: evaluation by using anti-Muellerian hormone. Lupus 2011; 20 (11) 1193-1197
    CrossrefPubMedSearch in Google Scholar
  • 30 Grossmann B, Saur S, Rall K. et al. Prevalence of autoimmune disease in women with premature ovarian failure. Eur J Contracept Reprod Health Care 2020; 25 (01) 72-75
    CrossrefPubMedSearch in Google Scholar
  • 31 Perez-Garcia LF, Te Winkel B, Carrizales JP. et al. Sexual function and reproduction can be impaired in men with rheumatic diseases: a systematic review. Semin Arthritis Rheum 2020; 50 (03) 557-573
    CrossrefPubMedSearch in Google Scholar
  • 32 Boussaid S, Makhlouf Y, Rekik S. et al. The effects of autoimmune rheumatic-related diseases on male reproductive health: a systematic review. J Reprod Immunol 2022; 150: 103472
    CrossrefPubMedSearch in Google Scholar
  • 33 Soares PMF, Borba EF, Bonfa E, Hallak J, Corrêa AL, Silva CAA. Gonad evaluation in male systemic lupus erythematosus. Arthritis Rheum 2007; 56 (07) 2352-2361
    CrossrefPubMedSearch in Google Scholar
  • 34 Edens C. The impact of pediatric rheumatic diseases on sexual health, family planning, and pregnancy. Rheum Dis Clin North Am 2022; 48 (01) 113-140
    CrossrefPubMedSearch in Google Scholar
  • 35 Girbash EF, Abdelwahab SM, Fahmi DS, Abdeldayem HM, Ghonaim R, Atta DS. Preliminary study on anti-Müllerian hormone, antral follicle count, menstruation and lymphocyte subsets in systemic lupus erythematosus patients. Int J Gynaecol Obstet 2022; 159 (01) 129-135
    CrossrefPubMedSearch in Google Scholar
  • 36 Di Mario C, Petricca L, Gigante MR. et al. Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: influence of the disease severity and therapy on the ovarian reserve. Endocrine 2019; 63 (02) 369-375
    CrossrefPubMedSearch in Google Scholar
  • 37 Franasiak JM, Forman EJ, Hong KH. et al. The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertil Steril 2014; 101 (03) 656-663.e1
    CrossrefPubMedSearch in Google Scholar
  • 38 Dooley MA, Nair R. Therapy insight: preserving fertility in cyclophosphamide-treated patients with rheumatic disease. Nat Clin Pract Rheumatol 2008; 4 (05) 250-257
    CrossrefPubMedSearch in Google Scholar
  • 39 Meistrich ML, Wilson G, Brown BW, da Cunha MF, Lipshultz LI. Impact of cyclophosphamide on long-term reduction in sperm count in men treated with combination chemotherapy for Ewing and soft tissue sarcomas. Cancer 1992; 70 (11) 2703-2712
    CrossrefPubMedSearch in Google Scholar
  • 40 Knight JS, Branch DW, Ortel TL. Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management. BMJ 2023; 380: e069717
    CrossrefPubMedSearch in Google Scholar
  • 41 Riancho-Zarrabeitia L, Martínez-Taboada V, Rúa-Figueroa I. et al. Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality. Lupus 2020; 29 (12) 1556-1565
    CrossrefPubMedSearch in Google Scholar
  • 42 Pons-Estel GJ, Andreoli L, Scanzi F, Cervera R, Tincani A. The antiphospholipid syndrome in patients with systemic lupus erythematosus. J Autoimmun 2017; 76: 10-20
    CrossrefPubMedSearch in Google Scholar
  • 43 El Hasbani G, Khamashta M, Uthman I. Antiphospholipid syndrome and infertility. Lupus 2020; 29 (02) 105-117
    CrossrefPubMedSearch in Google Scholar
  • 44 Shoenfeld Y, Carp HJA, Molina V. et al. Autoantibodies and prediction of reproductive failure. Am J Reprod Immunol 2006; 56 (5-6): 337-344
    CrossrefPubMedSearch in Google Scholar
  • 45 Ünlü O, Zuily S, Erkan D. The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus. Eur J Rheumatol 2016; 3 (02) 75-84
    CrossrefPubMedSearch in Google Scholar
  • 46 Chen HH, Lin CH, Chao WC. Risk of systemic lupus erythematosus in patients with anti-phospholipid syndrome: a population-based study. Front Med (Lausanne) 2021; 8: 654791
    CrossrefPubMedSearch in Google Scholar
  • 47 de Laat B, Gehlen R, de Groot PG. Viewpoint: the value of non-criteria antiphospholipid antibodies. Rheumatology (Oxford) 2024; 63 (SI): SI64-SI71
    CrossrefPubMedSearch in Google Scholar
  • 48 Bradacova P, Slavik L, Ulehlova J. et al. Current promising biomarkers and methods in the diagnostics of antiphospholipid syndrome: a review. Biomedicines 2021; 9 (02) 1-15
    CrossrefPubMedSearch in Google Scholar
  • 49 Sciascia S, Amigo MC, Roccatello D, Khamashta M. Diagnosing antiphospholipid syndrome: ‘extra-criteria’ manifestations and technical advances. Nat Rev Rheumatol 2017; 13 (09) 548-560
    CrossrefPubMedSearch in Google Scholar
  • 50 Miyakis S, Lockshin MD, Atsumi T. et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4 (02) 295-306
    CrossrefPubMedSearch in Google Scholar
  • 51 Barbhaiya M, Zuily S, Naden R. et al; ACR/EULAR APS Classification Criteria Collaborators. 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Ann Rheum Dis 2023; 82 (10) 1258-1270
    CrossrefPubMedSearch in Google Scholar
  • 52 Meroni PL, Borghi MO, Raschi E, Tedesco F. Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol 2011; 7 (06) 330-339
    CrossrefPubMedSearch in Google Scholar
  • 53 Rodrigues VO, Soligo AGES, Pannain GD. Antiphospholipid syndrome and infertility. Rev Bras Ginecol Obstet 2019; 41 (10) 621-627
    Thieme ConnectPubMedSearch in Google Scholar
  • 54 Tan X, Ding J, Pu D, Wu J. Anti-phospholipid antibody may reduce endometrial receptivity during the window of embryo implantation. J Gynecol Obstet Hum Reprod 2021; 50 (06) 101912
    CrossrefPubMedSearch in Google Scholar
  • 55 Paulmyer-Lacroix O, Despierres L, Courbiere B, Bardin N. Antiphospholipid antibodies in women undergoing in vitro fertilization treatment: clinical value of IgA anti-β2glycoprotein I antibodies determination. BioMed Res Int 2014; 2014: 314704
    CrossrefPubMedSearch in Google Scholar
  • 56 Ticconi C, Inversetti A, Logruosso E. et al. Antinuclear antibodies positivity in women in reproductive age: from infertility to adverse obstetrical outcomes - a meta-analysis. J Reprod Immunol 2023; 155: 103794
    CrossrefPubMedSearch in Google Scholar
  • 57 Deroux A, Dumestre-Perard C, Dunand-Faure C, Bouillet L, Hoffmann P. Female infertility and serum auto-antibodies: a systematic review. Clin Rev Allergy Immunol 2017; 53 (01) 78-86
    CrossrefPubMedSearch in Google Scholar
  • 58 Antonelli A, Fallahi P, Mosca M. et al. Prevalence of thyroid dysfunctions in systemic lupus erythematosus. Metabolism 2010; 59 (06) 896-900
    CrossrefPubMedSearch in Google Scholar
  • 59 Rahnama R, Mahmoudi AR, Kazemnejad S. et al. Thyroid peroxidase in human endometrium and placenta: a potential target for anti-TPO antibodies. Clin Exp Med 2021; 21 (01) 79-88
    CrossrefPubMedSearch in Google Scholar
  • 60 Meena M, Chopra S, Jain V, Aggarwal N. The effect of anti-thyroid peroxidase antibodies on pregnancy outcomes in euthyroid women. J Clin Diagn Res 2016; 10 (09) QC04-QC07
    PubMedSearch in Google Scholar
  • 61 Moncayo R, Moncayo HE. A new endocrinological and immunological syndrome in SLE: elevation of human chorionic gonadotropin and of antibodies directed against ovary and endometrium antigens. Lupus 1995; 4 (01) 39-45
    CrossrefPubMedSearch in Google Scholar
  • 62 Pasoto SG, Viana VS, Mendonca BB, Yoshinari NH, Bonfa E. Anti-corpus luteum antibody: a novel serological marker for ovarian dysfunction in systemic lupus erythematosus?. J Rheumatol 1999; 26 (05) 1087-1093
    PubMedSearch in Google Scholar
  • 63 Giannelou M, Mavragani CP. Cardiovascular disease in systemic lupus erythematosus: a comprehensive update. J Autoimmun 2017; 82: 1-12
    CrossrefPubMedSearch in Google Scholar
  • 64 Dumanski SM, Ahmed SB. Fertility and reproductive care in chronic kidney disease. J Nephrol 2019; 32 (01) 39-50
    CrossrefPubMedSearch in Google Scholar
  • 65 Ferrari-Souza JP, Pedrotti MT, Moretto EE, Farenzena LP, Crippa LG, Cunha-Filho JS. Endometriosis and systemic lupus erythematosus: systematic review and meta-analysis. Reprod Sci 2023; 30 (04) 997-1005
    CrossrefPubMedSearch in Google Scholar
  • 66 Arkema EV, Palmsten K, Sjöwall C, Svenungsson E, Salmon JE, Simard JF. What to expect when expecting with systemic lupus erythematosus (SLE): a population-based study of maternal and fetal outcomes in SLE and Pre-SLE. Arthritis Care Res (Hoboken) 2016; 68 (07) 988-994
    CrossrefPubMedSearch in Google Scholar
  • 67 Smyth A, Oliveira GHM, Lahr BD, Bailey KR, Norby SM, Garovic VD. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol 2010; 5 (11) 2060-2068
    CrossrefPubMedSearch in Google Scholar
  • 68 Buyon JP, Kim MY, Guerra MM. et al. Predictors of pregnancy outcome in a prospective, multiethnic cohort of lupus patients HHS public access. Ann Intern Med 2015; 163 (03) 153-163
    CrossrefPubMedSearch in Google Scholar
  • 69 Petri M. Pregnancy and systemic lupus erythematosus. Best Pract Res Clin Obstet Gynaecol 2020; 64: 24-30
    CrossrefPubMedSearch in Google Scholar
  • 70 Mankee A, Petri M, Magder LS. Lupus anticoagulant, disease activity and low complement in the first trimester are predictive of pregnancy loss. Lupus Sci Med 2015; 2 (01) e000095
    CrossrefPubMedSearch in Google Scholar
  • 71 Clowse MEB, Magder LS, Witter F, Petri M. Early risk factors for pregnancy loss in lupus. Obstet Gynecol 2006; 107 (2, Pt 1): 293-299
    CrossrefPubMedSearch in Google Scholar
  • 72 Clowse MEB, Magder LS, Witter F, Petri M. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum 2005; 52 (02) 514-521
    CrossrefPubMedSearch in Google Scholar
  • 73 Dimitriadis E, Menkhorst E, Saito S, Kutteh WH, Brosens JJ. Recurrent pregnancy loss. Nat Rev Dis Primers 2020; 6 (01) 98
    CrossrefPubMedSearch in Google Scholar
  • 74 Petri M. Antiphospholipid syndrome. Transl Res 2020:225:70–81
    PubMed
  • 75 Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R. et al; EUROAPS Study Group. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a survey of 1000 consecutive cases. Autoimmun Rev 2019; 18 (04) 406-414
    CrossrefPubMedSearch in Google Scholar
  • 76 Silver RM, Parker CB, Reddy UM. et al. Antiphospholipid antibodies in stillbirth. Obstet Gynecol 2013; 122 (03) 641-657
    CrossrefPubMedSearch in Google Scholar
  • 77 Moyer A, Chakravarty EF. Management of pregnancy in lupus. Rheum Dis Clin North Am 2021; 47 (03) 441-455
    CrossrefPubMedSearch in Google Scholar
  • 78 Zuppa AA, Riccardi R, Frezza S. et al. Neonatal lupus: Follow-up in infants with anti-SSA/Ro antibodies and review of the literature. Autoimmun Rev 2017; 16 (04) 427-432
    CrossrefPubMedSearch in Google Scholar
  • 79 Vanoni F, Lava SAG, Fossali EF. et al. Neonatal systemic lupus erythematosus syndrome: a comprehensive review. Clin Rev Allergy Immunol 2017; 53 (03) 469-476
    CrossrefPubMedSearch in Google Scholar
  • 80 Levesque K, Morel N, Maltret A. et al; “Lupus Néonatal” Group, Group of Collaborators. Description of 214 cases of autoimmune congenital heart block: results of the French neonatal lupus syndrome. Autoimmun Rev 2015; 14 (12) 1154-1160
    CrossrefPubMedSearch in Google Scholar
  • 81 Jaeggi E, Laskin C, Hamilton R, Kingdom J, Silverman E. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants. J Am Coll Cardiol 2010; 55 (24) 2778-2784
    CrossrefPubMedSearch in Google Scholar
  • 82 Izmirly PM, Saxena A, Kim MY. et al. Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus. Circulation 2011; 124 (18) 1927-1935
    CrossrefPubMedSearch in Google Scholar
  • 83 Lateef A, Petri M. Systemic lupus erythematosus and pregnancy. Rheum Dis Clin North Am 2017; 43 (02) 215-226
    CrossrefPubMedSearch in Google Scholar
  • 84 Chakravarty EF, Colón I, Langen ES. et al. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol 2005; 192 (06) 1897-1904
    CrossrefPubMedSearch in Google Scholar
  • 85 Eudy AM, Siega-Riz AM, Engel SM. et al. Effect of pregnancy on disease flares in patients with systemic lupus erythematosus. Ann Rheum Dis 2018; 77 (06) 855-860
    PubMedSearch in Google Scholar
  • 86 Davis-Porada J, Kim MY, Guerra MM. et al. Low frequency of flares during pregnancy and post-partum in stable lupus patients. Arthritis Res Ther 2020; 22 (01) 52
    CrossrefPubMedSearch in Google Scholar
  • 87 Stanhope TJ, White WM, Moder KG, Smyth A, Garovic VD. Obstetric nephrology: lupus and lupus nephritis in pregnancy. Clin J Am Soc Nephrol 2012; 7 (12) 2089-2099
    CrossrefPubMedSearch in Google Scholar
  • 88 Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum 1991; 34 (12) 1538-1545
    CrossrefPubMedSearch in Google Scholar
  • 89 Bremme K, Honkanen S, Gunnarsson I, Chaireti R. The presence of lupus nephritis additionally increases the risk of preeclampsia among pregnant women with systemic lupus erythematosus. Lupus 2021; 30 (07) 1031-1038
    CrossrefPubMedSearch in Google Scholar
  • 90 Wagner SJ, Craici I, Reed D. et al. Maternal and foetal outcomes in pregnant patients with active lupus nephritis. Lupus 2009; 18 (04) 342-347
    CrossrefPubMedSearch in Google Scholar
  • 91 Sangah AB, Jabeen S, Hunde MZ, Devi S, Mumtaz H, Shaikh SS. Maternal and fetal outcomes of SLE in pregnancy: a literature review. J Obstet Gynaecol 2023; 43 (01) 2205513
    CrossrefPubMedSearch in Google Scholar
  • 92 Maynard S, Guerrier G, Duffy M. Pregnancy in women with systemic lupus and lupus nephritis. Adv Chronic Kidney Dis 2019; 26 (05) 330-337
    CrossrefPubMedSearch in Google Scholar
  • 93 Bramham K, Hunt BJ, Bewley S. et al. Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis. J Rheumatol 2011; 38 (09) 1906-1913
    CrossrefPubMedSearch in Google Scholar
  • 94 Gibbins KJ, Tebo AE, Nielsen SK, Branch DW. Antiphospholipid antibodies in women with severe preeclampsia and placental insufficiency: a case-control study. Lupus 2018; 27 (12) 1903-1910
    CrossrefPubMedSearch in Google Scholar
  • 95 Ruiz-Irastorza G, Egurbide MV, Ugalde J, Aguirre C. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus. Arch Intern Med 2004; 164 (01) 77-82
    CrossrefPubMedSearch in Google Scholar
  • 96 Barańska-Pawełczak K, Wojciechowska C, Jacheć W. Pregnancy in patients with pulmonary arterial hypertension in light of new ESC guidelines on pulmonary hypertension. Int J Environ Res Public Health 2023; 20 (05) 4625
    CrossrefPubMedSearch in Google Scholar
  • 97 Nahal SK, Selmi C, Gershwin ME. Safety issues and recommendations for successful pregnancy outcome in systemic lupus erythematosus. J Autoimmun 2018; 93: 16-23
    CrossrefPubMedSearch in Google Scholar
  • 98 Skomsvoll JF, Ostensen M, Baste V, Irgens LM. Number of births, interpregnancy interval, and subsequent pregnancy rate after a diagnosis of inflammatory rheumatic disease in Norwegian women. J Rheumatol 2001; 28 (10) 2310-2314
    PubMedSearch in Google Scholar
  • 99 Silver R, Craigo S, Porter F, Osmundson SS, Kuller JA, Norton ME. Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org. Society for Maternal-Fetal Medicine Consult Series #64: systemic lupus erythematosus in pregnancy. Am J Obstet Gynecol 2023; 228 (03) B41-B60
    CrossrefPubMedSearch in Google Scholar
  • 100 Schreiber K, Sciascia S, de Groot P. et al. Antiphospholipid syndrome. Nat Rev Dis Primers 2018; 4: 17103
    CrossrefPubMedSearch in Google Scholar
  • 101 Izmirly P, Kim M, Friedman DM. et al. Hydroxychloroquine to prevent recurrent congenital heart block in fetuses of anti-SSA/Ro-positive mothers. J Am Coll Cardiol 2020; 76 (03) 292-302
    CrossrefPubMedSearch in Google Scholar
  • 102 Porter TF, Gyamfi-Bannerman C, Manuck T. ACOG Committee Opinion No. 743: low-dose aspirin use during pregnancy. Obstet Gynecol 2018; 132 (01) e44-e52
    CrossrefPubMedSearch in Google Scholar
  • 103 Andreoli L, Bertsias GK, Agmon-Levin N. et al. EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis 2017; 76 (03) 476-485
    CrossrefPubMedSearch in Google Scholar
  • 104 Fertility treatment use in the US | Pew Research Center. Accessed June 5, 2024 at: https://www.pewresearch.org/short-reads/2023/09/14/a-growing-share-of-americans-say-theyve-had-fertility-treatments-or-know-someone-who-has/
    PubMed
  • 105 Fact Sheet: In Vitro Fertilization (IVF) Use Across the United States | HHS.gov. Accessed August 13, 2024 at: https://www.hhs.gov/about/news/2024/03/13/fact-sheet-in-vitro-fertilization-ivf-use-across-united-states.html#footnote3_uj2r0sg
    PubMed
  • 106 NSFG - Listing I - Key Statistics from the National Survey of Family Growth. Accessed August 13, 2024 at: https://www.cdc.gov/nchs/nsfg/key_statistics/i.htm
    PubMed
  • 107 Wechsler B, Le Thi Huong D, Vauthier-Brouzes D, Lefebvre G, Gompel A, Piette JC. Can we advise ovulation induction in patients with SLE?. Scand J Rheumatol Suppl 1998; 107 (107) 53-59
    CrossrefPubMedSearch in Google Scholar
  • 108 Ben-Chetrit A, Ben-Chetrit E. Systemic lupus erythematosus induced by ovulation induction treatment. Arthritis Rheum 1994; 37 (11) 1614-1617
    CrossrefPubMedSearch in Google Scholar
  • 109 Huong DL, Wechsler B, Piette JC. et al. Risks of ovulation-induction therapy in systemic lupus erythematosus. Br J Rheumatol 1996; 35 (11) 1184-1186
    CrossrefPubMedSearch in Google Scholar
  • 110 Casoli P, Tumiati B, La Sala G. Fatal exacerbation of systemic lupus erythematosus after induction of ovulation. J Rheumatol 1997; 24 (08) 1639-1640
    PubMedSearch in Google Scholar
  • 111 Birru Talabi M, Eudy AM, Jayasundara M. et al. Pregnancy, periods, and “the pill”: exploring the reproductive experiences of women with inflammatory arthritis. ACR Open Rheumatol 2019; 1 (02) 125-132
    CrossrefPubMedSearch in Google Scholar
  • 112 Peninger E, Leavitt M, Edens C. et al. Fertility and the Use of Assisted Reproductive Technologies: Perceptions, Thoughts and Experiences of Men and Women with Rheumatic Disease. Arthritis and Rheumatology. Published 2022. Accessed June 5, 2024 at: http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed25&NEWS=N&AN=639967285
    PubMed
  • 113 Cutolo M, Straub RH. Sex steroids and autoimmune rheumatic diseases: state of the art. Nat Rev Rheumatol 2020; 16 (11) 628-644
    CrossrefPubMedSearch in Google Scholar
  • 114 Kim JW, Kim HA, Suh CH, Jung JY. Sex hormones affect the pathogenesis and clinical characteristics of systemic lupus erythematosus. Front Med (Lausanne) 2022; 9: 906475
    CrossrefPubMedSearch in Google Scholar
  • 115 Wu D, Ye L, Zhang X, Yin M, Guo Y, Zhou J. Characteristics of steroid hormones in systemic lupus erythematosus revealed by GC/MS-based metabolic profiling. Front Endocrinol (Lausanne) 2023; 14: 1164679
    CrossrefPubMedSearch in Google Scholar
  • 116 Walker SE. Estrogen and autoimmune disease. Clin Rev Allergy Immunol 2011; 40 (01) 60-65
    CrossrefPubMedSearch in Google Scholar
  • 117 Lao M, Dai P, Luo G. et al. Pregnancy outcomes in patients receiving assisted reproductive therapy with systemic lupus erythematosus: a multi-center retrospective study. Arthritis Res Ther 2023; 25 (01) 13
    CrossrefPubMedSearch in Google Scholar
  • 118 Huong DLT, Wechsler B, Vauthier-Brouzes D. et al. Importance of planning ovulation induction therapy in systemic lupus erythematosus and antiphospholipid syndrome: a single center retrospective study of 21 cases and 114 cycles. Semin Arthritis Rheum 2002; 32 (03) 174-188
    CrossrefPubMedSearch in Google Scholar
  • 119 Levine AB, Lockshin MD. Assisted reproductive technology in SLE and APS. Lupus 2014; 23 (12) 1239-1241
    CrossrefPubMedSearch in Google Scholar
  • 120 Reggia R, Andreoli L, Sebbar H. et al. An observational multicentre study on the efficacy and safety of assisted reproductive technologies in women with rheumatic diseases. Rheumatol Adv Pract 2019; 3 (01) rkz005
    CrossrefPubMedSearch in Google Scholar
  • 121 Orquevaux P, Masseau A, Le Guern V. et al. In vitro fertilization in 37 women with systemic lupus erythematosus or antiphospholipid syndrome: a series of 97 procedures. J Rheumatol 2017; 44 (05) 613-618
    CrossrefPubMedSearch in Google Scholar
  • 122 Guballa N, Sammaritano L, Schwartzman S, Buyon J, Lockshin MD. Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome. Arthritis Rheum 2000; 43 (03) 550-556
    CrossrefPubMedSearch in Google Scholar
  • 123 Mao R, Wang X, Long R, Wang M, Jin L, Zhu L. A new insight into the impact of systemic lupus erythematosus on oocyte and embryo development as well as female fertility. Front Immunol 2023; 14: 1132045
    CrossrefPubMedSearch in Google Scholar
  • 124 Kozlowski IF, Carneiro MC, Rosa VBD, Schuffner A. Correlation between anti-Müllerian hormone, age, and number of oocytes: a retrospective study in a Brazilian in vitro fertilization center. JBRA Assist Reprod 2022; 26 (02) 214-221
    PubMedSearch in Google Scholar
  • 125 Simopoulou M, Sfakianoudis K, Maziotis E. et al. The impact of autoantibodies on IVF treatment and outcome: a systematic review. Int J Mol Sci 2019; 20 (04) 892
    CrossrefPubMedSearch in Google Scholar
  • 126 Ying Y, Zhong YP, Zhou CQ. et al. Antinuclear antibodies predicts a poor IVF-ET outcome: impaired egg and embryo development and reduced pregnancy rate. Immunol Invest 2012; 41 (05) 458-468
    CrossrefPubMedSearch in Google Scholar
  • 127 Safarian GK, Niauri DA, Kogan IY. et al. Impact of antithyroperoxidase antibodies (anti-TPO) on ovarian reserve and early embryo development in assisted reproductive technology cycles. Int J Mol Sci 2023; 24 (05) 4705
    CrossrefPubMedSearch in Google Scholar
  • 128 Zhang S, Yang M, Li T. et al. High level of thyroid peroxidase antibodies as a detrimental risk of pregnancy outcomes in euthyroid women undergoing ART: a meta-analysis. Mol Reprod Dev 2023; 90 (04) 218-226
    CrossrefPubMedSearch in Google Scholar
  • 129 Li Y, Wang Y, Ma Y. et al. Investigation of the impact of antinuclear antibody on the outcome of in vitro fertilization/intracytoplasmic sperm injection treatment. Taiwan J Obstet Gynecol 2015; 54 (06) 742-748
    CrossrefPubMedSearch in Google Scholar
  • 130 Fang X, Lu F, Wang Y. et al. Anti-Ro/SSA and/or anti-La/SSB antibodies are associated with adverse IVF and pregnancy outcomes. J Reprod Immunol 2022; 149: 103459
    CrossrefPubMedSearch in Google Scholar
  • 131 Andreescu M. The impact of the use of immunosuppressive treatment after an embryo transfer in increasing the rate of live birth. Front Med (Lausanne) 2023; 10: 1167876
    CrossrefPubMedSearch in Google Scholar
  • 132 Parhizkar F, Motavalli-Khiavi R, Aghebati-Maleki L. et al. The impact of new immunological therapeutic strategies on recurrent miscarriage and recurrent implantation failure. Immunol Lett 2021; 236: 20-30
    CrossrefPubMedSearch in Google Scholar
  • 133 Peero EK, Banjar S, Khoudja R. et al. Intravenous immunoglobulin for patients with unexplained recurrent implantation failure: a 6-year single center retrospective review of clinical outcomes. Sci Rep 2024; 14 (01) 3876
    CrossrefPubMedSearch in Google Scholar
  • 134 Robertson SA, Jin M, Yu D. et al. Corticosteroid therapy in assisted reproduction - immune suppression is a faulty premise. Hum Reprod 2016; 31 (10) 2164-2173
    CrossrefPubMedSearch in Google Scholar
  • 135 Sun Y, Cui L, Lu Y. et al. Prednisone vs placebo and live birth in patients with recurrent implantation failure undergoing in vitro fertilization: a randomized clinical trial. JAMA 2023; 329 (17) 1460-1468
    CrossrefPubMedSearch in Google Scholar
  • 136 Boomsma CM, Kamath MS, Keay SD, Macklon NS. Peri-implantation glucocorticoid administration for assisted reproductive technology cycles. Cochrane Database Syst Rev 2022; 6 (06) CD005996
    PubMedSearch in Google Scholar
  • 137 Eapen A, Joing M, Kwon P. et al; RESPONSE Study Group. Recombinant human granulocyte- colony stimulating factor in women with unexplained recurrent pregnancy losses: a randomized clinical trial. Hum Reprod 2019; 34 (03) 424-432
    CrossrefPubMedSearch in Google Scholar
  • 138 He M, Sun X, Wang C, Sui Y. Analysis of the risk of complications during pregnancy in pregnant women with assisted reproductive technology: a retrospective study using registry linkage from 2013 to 2018 in Shanghai, China. BMC Pregnancy Childbirth 2022; 22 (01) 526
    CrossrefPubMedSearch in Google Scholar
  • 139 Bates SM. Anticoagulation and in vitro fertilization and ovarian stimulation. Hematology (Am Soc Hematol Educ Program) 2014; 2014 (01) 379-386
    CrossrefPubMedSearch in Google Scholar
  • 140 Petri M, Kim MY, Kalunian KC. et al; OC-SELENA Trial. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 2005; 353 (24) 2550-2558
    CrossrefPubMedSearch in Google Scholar
  • 141 American College of Obstetricians and Gynecologists. Society for Maternal-Fetal Medicine, Bryant A, et al. Low-Dose Aspirin Use for the Prevention of Preeclampsia and Related Morbidity and Mortality | ACOG. Published October 2022. Accessed June 9, 2024 at: https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2021/12/low-dose-aspirin-use-for-the-prevention-of-preeclampsia-and-related-morbidity-and-mortality
    PubMed
  • 142 Davidson KW, Barry MJ, Mangione CM. et al; US Preventive Services Task Force. Aspirin use to prevent preeclampsia and related morbidity and mortality: US Preventive Services Task Force Recommendation Statement. JAMA 2021; 326 (12) 1186-1191
    CrossrefPubMedSearch in Google Scholar
  • 143 Rosendaal FR, Helmerhorst FM, Vandenbroucke JP. Female hormones and thrombosis. Arterioscler Thromb Vasc Biol 2002; 22 (02) 201-210
    CrossrefPubMedSearch in Google Scholar
  • 144 Kaiser R, Cleveland CM, Criswell LA. Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort. Ann Rheum Dis 2009; 68 (02) 238-241
    CrossrefPubMedSearch in Google Scholar
  • 145 Moffat R, Hansali C, Schoetzau A. et al. Randomised controlled trial on the effect of clomiphene citrate and gonadotropin dose on ovarian response markers and IVF outcomes in poor responders. Hum Reprod 2021; 36 (04) 987-997
    CrossrefPubMedSearch in Google Scholar
  • 146 Al-Inany HG, Youssef MA, Aboulghar M. et al. GnRH antagonists are safer than agonists: an update of a Cochrane review. Hum Reprod Update 2011; 17 (04) 435
    CrossrefPubMedSearch in Google Scholar
  • 147 Li X, Chen J, Zhao Y. et al. The effect of letrozole overlapped with gonadotropin on IVF outcomes in women with DOR or aged over 40 years old with repeated cycles. J Ovarian Res 2023; 16 (01) 193
    CrossrefPubMedSearch in Google Scholar
  • 148 Bülow NS, Dreyer Holt M, Skouby SO. et al. Co-treatment with letrozole during ovarian stimulation for IVF/ICSI: a systematic review and meta-analysis. Reprod Biomed Online 2022; 44 (04) 717-736
    CrossrefPubMedSearch in Google Scholar
  • 149 Palomba S, Costanzi F, Nelson SM, Caserta D, Humaidan P. Interventions to prevent or reduce the incidence and severity of ovarian hyperstimulation syndrome: a systematic umbrella review of the best clinical evidence. Reprod Biol Endocrinol 2023; 21 (01) 67
    CrossrefPubMedSearch in Google Scholar
  • 150 Crochet JR, Yeh JS, Clowse MEB, Copland SD. Late ovarian hyperstimulation syndrome after controlled ovarian stimulation in a woman with systemic lupus erythematosus and lupus nephritis. Fertil Steril 2011; 95 (05) 1786.e13-1786.e16
    CrossrefPubMedSearch in Google Scholar
  • 151 Weinreb EB, Cholst IN, Ledger WJ, Danis RB, Rosenwaks Z. Should all oocyte donors receive prophylactic antibiotics for retrieval?. Fertil Steril 2010; 94 (07) 2935-2937
    CrossrefPubMedSearch in Google Scholar
  • 152 Pereira N, Hutchinson AP, Lekovich JP, Hobeika E, Elias RT. Antibiotic prophylaxis for gynecologic procedures prior to and during the utilization of assisted reproductive technologies: a systematic review. J Pathogens 2016; 2016: 4698314
    CrossrefPubMedSearch in Google Scholar
  • 153 Ameratunga D, Yazdani A, Kroon B. Antibiotics prior to or at the time of embryo transfer in ART. Cochrane Database Syst Rev 2023; 11 (11) CD008995
    PubMedSearch in Google Scholar
  • 154 Kroon B, Hart RJ, Wong BM, Ford E, Yazdani A. Antibiotics prior to embryo transfer in ART. Cochrane Database Syst Rev 2012; (03) CD008995
    PubMedSearch in Google Scholar
  • 155 Penzias A, Bendikson K, Butts S. et al; Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org, Practice Committee of the American Society for Reproductive Medicine. Performing the embryo transfer: a guideline. Fertil Steril 2017; 107 (04) 882-896
    CrossrefPubMedSearch in Google Scholar
  • 156 Lemardeley G, Porcu-Buisson G, Pirrello O. et al. Contribution of medico-administrative databases to health vigilance: example of post-oocyte retrieval infections. Hum Reprod 2024; 39 (01) 190-200
    CrossrefPubMedSearch in Google Scholar
  • 157 Bonus ML, Boots C, Bernardi LA. Antibiotics before frozen embryo transfer: treating the patient or the physician?. Fertil Steril 2021; 115 (05) 1162-1163
    CrossrefPubMedSearch in Google Scholar
  • 158 Johnston M, Richings NM, Leung A, Sakkas D, Catt S. A major increase in oocyte cryopreservation cycles in the USA, Australia and New Zealand since 2010 is highlighted by younger women but a need for standardized data collection. Hum Reprod 2021; 36 (03) 624-635
    CrossrefPubMedSearch in Google Scholar
  • 159 Borate GM, Meshram A. Cryopreservation of sperm: a review. Cureus 2022; 14 (11) e31402
    PubMedSearch in Google Scholar
  • 160 Doyle JO, Richter KS, Lim J, Stillman RJ, Graham JR, Tucker MJ. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval. Fertil Steril 2016; 105 (02) 459-66.e2
    CrossrefPubMedSearch in Google Scholar
  • 161 BWH Egg Freezing Counseling Tool (EFCT). Accessed August 10, 2024 at: https://www.mdcalc.com/calc/3937/bwh-egg-freezing-counseling-tool-efct#evidence
    PubMed
  • 162 OPIS IVF Calculator - Getting Started. Accessed August 10, 2024 at: https://w3.abdn.ac.uk/clsm/opis/home/toolintro
    PubMed
  • 163 Goldman RH, Racowsky C, Farland LV, Munné S, Ribustello L, Fox JH. Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients. Hum Reprod 2017; 32 (04) 853-859
    CrossrefPubMedSearch in Google Scholar
  • 164 Cacciottola L, Donnez J, Dolmans MM. Ovarian tissue and oocyte cryopreservation prior to iatrogenic premature ovarian insufficiency. Best Pract Res Clin Obstet Gynaecol 2022; 81: 119-133
    CrossrefPubMedSearch in Google Scholar
  • 165 Oktay K, Harvey BE, Partridge AH. et al. Fertility preservation in patients with cancer: ASCO Clinical Practice Guideline Update. J Clin Oncol 2018; 36 (19) 1994-2001
    CrossrefPubMedSearch in Google Scholar
  • 166 Bahroudi Z, Zarnaghi MR, Izadpanah M. et al. Review of ovarian tissue cryopreservation techniques for fertility preservation. J Gynecol Obstet Hum Reprod 2022; 51 (02) 102290
    CrossrefPubMedSearch in Google Scholar
  • 167 Practice Committee of the American Society for Reproductive Medicine. Electronic address: asrm@asrm.org. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril 2019; 112 (06) 1022-1033
    CrossrefPubMedSearch in Google Scholar
  • 168 Ramirez T, Pavone M. Exploring the frontiers of ovarian tissue cryopreservation: a review. J Clin Med 2024; 13 (15) 4513
    CrossrefPubMedSearch in Google Scholar
  • 169 Cvetanovic AS, Lambertini M, Punie K. et al. Pharmacological methods for ovarian function and fertility preservation in women with cancer: a literature review. Oncol Res 2024; 32 (08) 1309-1322
    CrossrefPubMedSearch in Google Scholar
  • 170 Blumenfeld Z. How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embryo, oocytes, or ovaries. Oncologist 2007; 12 (09) 1044-1054
    CrossrefPubMedSearch in Google Scholar
  • 171 Ejaz K, Abid D, Juneau P, Chu J, Hasni S. Use of gonadotropin-releasing hormone agonists for ovarian preservation in patients receiving cyclophosphamide for systemic lupus erythematosus: a meta-analysis. Lupus 2022; 31 (14) 1706-1713
    CrossrefPubMedSearch in Google Scholar
  • 172 Salih Joelsson L, Tydén T, Wanggren K. et al. Anxiety and depression symptoms among sub-fertile women, women pregnant after infertility treatment, and naturally pregnant women. Eur Psychiatry 2017; 45: 212-219
    CrossrefPubMedSearch in Google Scholar
  • 173 Zhang L, Fu T, Yin R, Zhang Q, Shen B. Prevalence of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysis. BMC Psychiatry 2017; 17 (01) 70
    CrossrefPubMedSearch in Google Scholar
  • 174 Moghadam ZB, Rezaei E, Faezi ST, Zareian A, Ibrahim FM, Ibrahim MM. Prevalence of sexual dysfunction in women with systemic lupus erythematosus and its related factors. Reumatologia 2019; 57 (01) 19-26
    CrossrefPubMedSearch in Google Scholar
  • 175 Crawford NM, Hoff HS, Mersereau JE. Infertile women who screen positive for depression are less likely to initiate fertility treatments. Hum Reprod 2017; 32 (03) 582-587
    PubMedSearch in Google Scholar
  • 176 Salari N, Babajani F, Hosseinian-Far A. et al. Global prevalence of major depressive disorder, generalized anxiety, stress, and depression among infertile women: a systematic review and meta-analysis. Arch Gynecol Obstet 2024; 309 (05) 1833-1846
    CrossrefPubMedSearch in Google Scholar
  • 177 Franca UL, Adler A, Ramirez LB. Geographic disparities in access to fertility services in the United States. Fertil Steril 2021; 116 (03) e321
    CrossrefPubMedSearch in Google Scholar
  • 178 How Much Does IVF Cost In. 2024? – Forbes Health. Accessed August 13, 2024 at: https://www.forbes.com/health/womens-health/how-much-does-ivf-cost/
    PubMed
  • 179 Pryor KP, Barbhaiya M, Costenbader KH, Feldman CH. Disparities in lupus and lupus nephritis care and outcomes among US Medicaid beneficiaries. Rheum Dis Clin North Am 2021; 47 (01) 41-53
    CrossrefPubMedSearch in Google Scholar
  • 180 Merkison JM, Chada AR, Marsidi AM, Spencer JB. Racial and ethnic disparities in assisted reproductive technology: a systematic review. Fertil Steril 2023; 119 (03) 341-347
    CrossrefPubMedSearch in Google Scholar
  • 181 Charras A, Smith E, Hedrich CM. Systemic lupus erythematosus in children and young people. Curr Rheumatol Rep 2021; 23 (03) 20
    CrossrefPubMedSearch in Google Scholar
  • 182 Mina R, Brunner HI. Pediatric lupus – are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?. Rheum Dis Clin North Am 2010; 36 (01) 53-80 , vii–viii
    CrossrefPubMedSearch in Google Scholar
  • 183 Ghidei L, Wiltshire A, Raker C, Ayyar A, Brayboy LM. Factors associated with disparate outcomes among Black women undergoing in vitro fertilization. F S Rep 2021; 3 (2, Suppl): 14-21
    PubMedSearch in Google Scholar
  • 184 Chen AB, Jarvi KA, Lajkosz K. et al. One size does not fit all: variations by ethnicity in demographic characteristics of men seeking fertility treatment across North America. Fertil Steril 2021; 116 (05) 1287-1294
    CrossrefPubMedSearch in Google Scholar
  • 185 Katz P, Yazdany J, Julian L. et al. Impact of obesity on functioning among women with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2011; 63 (10) 1357-1364
    CrossrefPubMedSearch in Google Scholar
  • 186 Fryar CD, Carroll MD, Afful J. Health E-Stats December 2020. Natl Heal Nutr Exam Surv 1960
    CrossrefPubMedSearch in Google Scholar
  • 187 Jain T. Socioeconomic and racial disparities among infertility patients seeking care. Fertil Steril 2006; 85 (04) 876-881
    CrossrefPubMedSearch in Google Scholar
  • 188 Lieber R. A Baby or Your Money Back: All About Fertility Clinic Package Deals - The New York Times. Published April 15, 2017. Accessed September 24, 2024 at: https://www.nytimes.com/2017/04/14/your-money/baby-fertility-clinic-package-deals.html?searchResultPosition=2
    PubMed
  • 189 Koning A, Mol BW, Dondorp W. It is not justified to reject fertility treatment based on obesity. Hum Reprod Open 2017; 2017 (02) hox009
    CrossrefPubMedSearch in Google Scholar
  • 190 Klitzman R. Gatekeepers for infertility treatment? Views of ART providers concerning referrals by non-ART providers. Reprod Biomed Soc Online 2017; 5: 17-30
    CrossrefPubMedSearch in Google Scholar
  • 191 He L, Arenas G, Karani R, Faison M, Dade A. A womb with rheum: providers' knowledge and educational needs in caring for women with rheumatic diseases. Published online June 6, 2023
    CrossrefPubMed
  • 192 2020 National ART Summary | CDC. Accessed June 5, 2024 at: https://www-cdc-gov.laneproxy.stanford.edu/art/reports/2020/summary.html
    PubMed
  • 193 Surrogacy Laws By State - Legal Professional Group. Accessed June 9, 2024 at: https://connect.asrm.org/lpg/resources/surrogacy-by-state?ssopc=1
    PubMed
  • 194 Kooli C. Review of assisted reproduction techniques, laws, and regulations in Muslim countries. Middle East Fertil Soc J 2019; 24 (01)
    CrossrefPubMedSearch in Google Scholar
  • 195 Current Law – Surrogacy360. Accessed June 9, 2024 at: https://surrogacy360.org/considering-surrogacy/current-law/
    PubMed
  • 196 Blazier J, Janssens R. Regulating the international surrogacy market: the ethics of commercial surrogacy in the Netherlands and India. Med Health Care Philos 2020; 23 (04) 621-630
    CrossrefPubMedSearch in Google Scholar
  • 197 Saxena P, Mishra A, Malik S. Surrogacy: ethical and legal issues. Indian J Community Med 2012; 37 (04) 211-213
    CrossrefPubMedSearch in Google Scholar
  • 198 Mackworth-Young CG, Parke AL, Morley KD, Fotherby K, Hughes GR. Sex hormones in male patients with systemic lupus erythematosus: a comparison with other disease groups. Eur J Rheumatol Inflamm 1983; 6 (03) 228-232
    PubMedSearch in Google Scholar
  • 199 Giambalvo S, Garaffoni C, Silvagni E. et al. Factors associated with fertility abnormalities in women with systemic lupus erythematosus: a systematic review and meta-analysis. Autoimmun Rev 2022; 21 (04) 103038
    CrossrefPubMedSearch in Google Scholar
  • 200 Micu MC, Micu R, Ostensen M. Luteinized unruptured follicle syndrome increased by inactive disease and selective cyclooxygenase 2 inhibitors in women with inflammatory arthropathies. Arthritis Care Res (Hoboken) 2011; 63 (09) 1334-1338
    CrossrefPubMedSearch in Google Scholar
  • 201 Bermas BL. Paternal safety of anti-rheumatic medications. Best Pract Res Clin Obstet Gynaecol 2020; 64: 77-84
    CrossrefPubMedSearch in Google Scholar
  • 202 Mohammed AG, Mansour AA, Ahmed JH. Effect of exogenous glucocorticoids on male hypogonadism. Biomed Rep 2020; 13 (03) 12
    PubMedSearch in Google Scholar
  • 203 Jin Z, Yang C, Xiao C, Wang Z, Zhang S, Ren J. Systemic lupus erythematosus and risk of sexual dysfunction: a systematic review and meta-Analysis. Lupus 2021; 30 (02) 238-247
    CrossrefPubMedSearch in Google Scholar
  • 204 Ponticelli C, Moroni G. Fetal toxicity of immunosuppressive drugs in pregnancy. J Clin Med 2018; 7 (12) 552
    CrossrefPubMedSearch in Google Scholar
  • 205 FDA. CellCept® (mycophenolate mofetil capsules) (mycophenolate mofetil tablets) CellCept® Oral Suspension (mycophenolate mofetil for oral suspension) CellCept® Intravenous (mycophenolate mofetil hydrochloride for injection) U.S. Food and Drug Administration. Highlights of Prescribing Information for Cellcept. Accessed November 3, 2024 at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050722s050,050723s050,050758s048,050759s055lbl.pdf
    PubMed
  • 206 FDA, CDER. Highlights of Prescribing Information. Accessed May 5, 2024 at: www.fda.gov/medwatch
    PubMed
  • 207 Lloyd ME, Carr M, McElhatton P, Hall GM, Hughes RA. The effects of methotrexate on pregnancy, fertility and lactation. QJM 1999; 92 (10) 551-563
    CrossrefPubMedSearch in Google Scholar
  • 208 U.S. Food and Drug Administration. Highlights of Prescribing Information for Arava (leflunomide). Accessed May 5, 2024 at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020905s033lbl.pdf
    PubMed
  • 209 Fu J, Tomlinson G, Feig DS. Increased risk of major congenital malformations in early pregnancy use of angiotensin-converting-enzyme inhibitors and angiotensin-receptor-blockers: a meta-analysis. Diabetes Metab Res Rev 2021; 37 (08) e3453
    CrossrefPubMedSearch in Google Scholar
  • 210 FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later because they can result in low amniotic fluid | FDA. Accessed May 5, 2024 at: https://www.fda.gov/drugs/drug-safety-and-availability/fda-recommends-avoiding-use-nsaids-pregnancy-20-weeks-or-later-because-they-can-result-low-amniotic
    PubMed
  • 211 Clowse MEB. Lupus activity in pregnancy. Rheum Dis Clin North Am 2007; 33 (02) 237-252 , v
    CrossrefPubMedSearch in Google Scholar
  • 212 Wu J, Ma J, Zhang WH, Di W. Management and outcomes of pregnancy with or without lupus nephritis: a systematic review and meta-analysis. Ther Clin Risk Manag 2018; 14: 885-901
    CrossrefPubMedSearch in Google Scholar
  • 213 Brito-Zerón P, Izmirly PM, Ramos-Casals M, Buyon JP, Khamashta MA. Autoimmune congenital heart block: complex and unusual situations. Lupus 2016; 25 (02) 116-128
    CrossrefPubMedSearch in Google Scholar